Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Innovation Pharmaceuticals Inc (CE) | IPIX | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0007 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0007 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0001 - 0.023 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0007 | USD |
Innovation Pharmaceuticals Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 514.01M | 342.36M | 0 | -3.17M | -0.01 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innovation Pharmaceuticals (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/01/2024 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/05/2023 | 15:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/20/2023 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/15/2023 | 07:00 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 10/30/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/28/2023 | 08:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IPIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00185 | 0.0021 | 0.0004 | 0.0004314 | 288,597 | -0.00115 | -62.16% |
| 1 Month | 0.0141 | 0.0195 | 0.0001 | 0.0082143 | 369,164 | -0.0134 | -95.04% |
| 3 Months | 0.0061 | 0.0195 | 0.0001 | 0.0107803 | 524,159 | -0.0054 | -88.52% |
| 6 Months | 0.007 | 0.0195 | 0.0001 | 0.0090727 | 651,898 | -0.0063 | -90.00% |
| 1 Year | 0.0179 | 0.023 | 0.0001 | 0.0106533 | 483,931 | -0.0172 | -96.09% |
| 3 Years | 0.1921 | 0.54 | 0.0001 | 0.100221 | 1,009,290 | -0.1914 | -99.64% |
| 5 Years | 0.287 | 0.65 | 0.0001 | 0.171661 | 1,309,574 | -0.2863 | -99.76% |
Innovation Pharmaceuticals (CE) Description
| An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers. |
